Gupta, Arun Kumar and Parwe, Shweta and Gupta, Trupti and Nisargandha, Milind (2021) A comparative Clinical Study to Evaluate the Efficacy of Anuvasan Basti with Brahatchaglyadi Ghritam and Guggulutiktam Ghritam in the management of Gridhrasi (Sciatica): A Study Protocol. Journal of Pharmaceutical Research International, 33 (30A). pp. 119-136. ISSN 2456-9119
2441-Article Text-4106-1-10-20221006.pdf - Published Version
Download (254kB)
Abstract
Background: Gridhrasi is such a Ruja Pradhaana Vatavyadhi. In Gridhrasi intense shooting pain characteristically radiates from Sphika (gluteal region) to Pada (foot). Based on symptoms of Gridhrasi, it can be equated with the disease sciatica in modern science. The lifetime incidence of low back pain is 50-70%, with Sciatica more than 40%. Charaka has considered Basti therapy as half of the disease's treatment, while some authors consider it as the complete remedy for all the ailments. Basti is one of the unique procedures explained for the management of Vatavyadhi (Neurological Disorder) where Gridhrasi (Sciatica) is being the predominant of Vata dosha, Basti is being used widely for the management of Gridhrasi (Sciatica). Therefore we have taken the Basti modality for the treatment of Gridhrasi (Sciatica). Hence the study is carried to evaluate the effect of Anuvasanbasti with Brihachagalyadi Ghritam & Guggulutiktaka Ghritam in the management of Gridhrasi (Sciatica).
Aims and Objectives: Evaluate Anuvasan Basti's efficacy with Brihatchagalyadi Ghritam & Guggulutiktaka Ghritamin the control of Gridhrasi (Sciatica) and to compare the effectiveness of Brihachagalyad Ghritam & Guggulutiktak Ghritam Anuvasan Basti in the direction of Gridhrasi. Methodology: Procedure: This study, a total of 66 patients, will be separated haphazardly divided into 2 groups (33 in each). In Group A (Interventional Group)- will Treat with Brihachagalyadi Ghritam as an Anuvasan Basti in increasing dose pattern for nine days and Group B (Control Group ) –patients will Treat with Guggulutiktaka Ghritam as an Anuvasanbasti in increasing dose pattern for nine days. The evaluation will be recorded on 0 and 9thday.
Conclusion: It may be more beneficial and more effective in pain as well as other subjective and objective parameters.
Item Type: | Article |
---|---|
Subjects: | Universal Eprints > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 21 Feb 2023 04:49 |
Last Modified: | 30 May 2024 05:39 |
URI: | http://journal.article2publish.com/id/eprint/606 |